Sign in

CIK 0001601830

  • Large accelerated filer

RECURSION PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464099738
Phone
+1 385-269-0203
Business address
41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
Former names
Recursion Pharmaceuticals, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$701,222
in 5 filings, $701K under 10b5-1 plans

Net −$701,222. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-05 Gibson Christopher Director Conversion 10b5-1 +40,000 923,735
2026-06-05 Gibson Christopher Director Sale 10b5-1 −40,000 $3.62 $145K 883,735
2026-06-05 Gibson Christopher Director Conversion · Class B Common Stock 10b5-1 −40,000 4,263,334
2026-05-22 Gibson Christopher Director Conversion 10b5-1 +40,000 923,735
2026-05-22 Gibson Christopher Director Sale 10b5-1 −40,000 $3.08 $123K 883,735
2026-05-22 Gibson Christopher Director Conversion · Class B Common Stock 10b5-1 −40,000 4,303,334
2026-05-15 Gibson Christopher Director Shares withheld for taxes −22,821 $3.04 $69K 883,735
2026-05-07 Gibson Christopher Director Conversion 10b5-1 +60,000 966,556
2026-05-07 Gibson Christopher Director Sale 10b5-1 −40,000 $3.37 $135K 926,556
2026-05-07 Gibson Christopher Director Gift 10b5-1 −20,000 906,556
2026-05-07 Gibson Christopher Director Conversion · Class B Common Stock 10b5-1 −60,000 4,343,334
2026-04-22 Gibson Christopher Director Conversion 10b5-1 +40,000 946,556
2026-04-22 Gibson Christopher Director Sale 10b5-1 −40,000 $3.61 $144K 906,556
2026-04-22 Gibson Christopher Director Conversion · Class B Common Stock 10b5-1 −40,000 4,403,334
2026-04-07 Gibson Christopher Director Conversion 10b5-1 +40,000 946,556
2026-04-07 Gibson Christopher Director Sale 10b5-1 −40,000 $3.10 $124K 906,556
2026-04-07 Gibson Christopher Director Conversion · Class B Common Stock 10b5-1 −40,000 4,443,334
2026-03-23 Gibson Christopher Director Conversion 10b5-1 +40,000 946,556
2026-03-23 Gibson Christopher Director Sale 10b5-1 −40,000 $3.25 $130K 906,556
2026-03-23 Gibson Christopher Director Conversion · Class B Common Stock 10b5-1 −40,000 4,483,334

Page 1 of 11 · 203 trades